Corti opens clinical-AI platform to startups amid EU regulatory shift

The Copenhagen-based clinical AI company Corti has unveiled a no-equity accelerator for healthcare and life sciences startups, granting founders worldwide access to its Symphony model stack. This move arrives at a pivotal moment as the European Union reshapes its regulatory framework for artificial intelligence in medicine.

Corti reports that its Symphony model has surpassed OpenAI’s performance on the HealthBench Professional benchmark, a key metric for clinical reasoning. The accelerator offers credits and regulatory guidance to help startups build and deploy AI solutions in healthcare without giving up ownership.

By opening its platform to external innovators, Corti aims to accelerate the development of clinical AI applications that can improve patient outcomes and streamline medical workflows. The timing is strategic: with new EU regulations on AI in healthcare taking shape, startups often struggle to navigate compliance. Corti’s program provides direct support to address that hurdle.

The company’s focus on no-equity acceleration distinguishes it from traditional venture-backed incubators. Founders retain full control of their intellectual property while gaining access to Corti’s advanced AI infrastructure and expertise in clinical deployment.

This initiative signals a broader shift in the healthtech ecosystem, where established players increasingly empower smaller teams to build on their technology. For startups eyeing the regulated healthcare market, Corti’s offer of both technical firepower and regulatory scaffolding could prove decisive.